Results for methodological translation from Portuguese to English

methodological manual .
methodological manual .

theoretical and methodological orientations.
theoretical and methodological orientations.

) "network analysis: methodological foundations", pp.
) "network analysis: methodological foundations", pp.

"a methodological enquiry: the great bronze athena by pheidias".
athena was the goddess of wisdom and warriors and the protector of athens.

points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
inferiority margin points to consider on biostatistical/methodological issues arising

methodological remarks : the starting point in the year 2000 is set in the graph as zero and the 2010 benchmark as 100.
methodological remarks : the starting point in the year 2000 is set in the graph as zero and the 2010 benchmark as 100.

concept paper on the development of a cpmp points to consider on methodological issues in confirmatory clinical trials with flexible design and analysis plan.
concept paper on the development of a cpmp points to consider on methodological issues in confirmatory clinical trials with flexible design and analysis plan.

página 41/59points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications:
points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications:adjustment forbaseline covariatespoints to consider on the use of statistical methods for flexible

adjustment for multiplicity and related topics points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
adjustment for multiplicity and related topics points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:

choice of non-inferiority margin points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications:
design and analysis of confirmatory clinical trialspoints to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins

« methodological notes for the compilation of the revaluation adjustment » , fevereiro de 2006 ( disponível apenas online ) .
« methodological notes for the compilation of the revaluation adjustment » , february 2006 ( online only ) .

o projeto, denominado methodological cosmopolitanism - in the laboratory of climate change cosmo-climate, foi financiado pelo european research council pelo período de 5 anos.
the project, named methodological cosmopolitanism - in the laboratory of climate change cosmo-climate, was financed by the european research council for a 5-year period.

o the methodological reader publicado pela alliance for health policy and systems research em 2012 classifica os desenhos de pesquisa nessa área em duas principais estratégias de pesquisa: desenhos fixos que são estabelecidos antes da coleta de dados, e desenhos flexíveis que evoluem durante o processo de estudo.
the methodological reader, published by the alliance for health policy and systems research in 2012, classifies research designs in this area in two main research strategies: fixed designs that are established prior to data collection, and flexible designs that evolve during the study process.

emea/mb/050/00 relatório anual 2000 page 85/88 note for guidance on the clinical emea/cpmp/bpwg/198/95 publicado para consulta em junho de investigation of human plasma derived rev.1 2000 factor viii and ix products note for guidance on the clinical publicado para consulta em junho de emea/cpmp/bpwg/1561/99 investigation of recombinant factor viii 2000 and ix products emea/cpmp/phvwp/bpwg/publicado para consulta em junho de core spc for human albumin 2231/99 2000 note for guidance on the clinical publicado para consulta em emea/cpmp/bpwg/2220/99 investigation of plasma derived dezembro de 2000 antithrombin products core spc for human plasma derived publicado para consulta em emea/cpmp/bpwg/3226/99 antithrombin dezembro de 2000 grupo de trabalho " eficácia " do cpmp número de referência linhas de orientação situação note for guidance on clinical investigation emea/cpmp/ewp/519/98 aprovada em fevereiro de 2000 of steroid contraceptives in woman points to consider concerning endpoints in clinical studies with haematopoietic growth emea/cpmp/ewp/197/99 aprovada em fevereiro de 2000 factors for mobilisation of autologous stem cells points to consider on the clinical investigation of new medicinal products for emea/cpmp/ewp/570/98 treatment of acute coronary syndrome aprovada em fevereiro de 2000 (acs) without persistent st-segment elevation concept paper on the development of a cpmp note for guidance on the clinical emea/cpmp/ewp/2922/99 aprovada em fevereiro de 2000 investigation of medicinal products in the treatment of asthma concept paper on the development of a cpmp points to consider on biostatistical/methodological issues arising emea/cpmp/ewp/2863/99 aprovada em fevereiro de 2000 from cpmp discussions on licensing applications: adjustment for baseline covariates points to consider on clinical investigation of medicinal products for prophylaxis of emea/cpmp/ewp/707/98 aprovada em junho de 2000 intra -and post-operative venous thromboembolic risk concept paper on the development of a cpmp note for guidance on the clinical emea/cpmp/ewp/612/00 aprovada em junho de 2000 investigation of medicinal products in pain management points to consider on pharmaco-kinetics emea/cpmp/ewp/2655/99 and pharmacodynamics in the development aprovada em julho de 2000 of anti-bacterial medicinal products points to consider on switching between emea/cpmp/ewp/482/99 aprovada em julho de 2000 superiority and non-inferiority concept paper on the development of a cpmp note for guidance on clinical emea/cpmp/ewp/1080/00 aprovada em julho de 2000 investigation of medicinal products in the treatment of diabetes mellitus points to consider on clinical investigation emea/cpmp/ewp/565/98 of medicinal products for treatment of aprovada em outubro de 2000 amyotrophic lateral sclerosis (als) concept paper on the evaluation of drugs emea/cpmp/ewp/785/97 for the treatment of the irritable bowel aprovada em novembro de 2000 syndrome note for guidance on clinical investigation emea/cpmp/ewp/566/98 rev.
guidelines/status note for guidance on clinical investigation of steroid contraceptives in woman adopted february 2000 points to consider concerning endpoints in clinical studies with haematopoietic growth factors for mobilisation of autologous stem cells adopted february 2000 points to consider on the clinical investigation of new medicinal products for treatment of acute coronary syndrome (acs) without persistent st-segment elevation adopted february 2000 concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products in the treatment of asthma adopted february 2000 concept paper on the development of a cpmp points to consider on biostatistical/methodological issues arising from cpmp discussions on licensing applications: adjustment for baseline covariates adopted february 2000 points to consider on clinical investigation of medicinal products for prophylaxis of intra-and post-operative venous thromboembolic risk adopted june 2000 concept paper on the development of a cpmp note for guidance on the clinical investigation of medicinal products in pain management adopted june 2000 points to consider on pharmaco-kinetics and pharmacodynamics in the development of anti-bacterial medicinal products adopted july 2000 points to consider on switching between superiority and non-inferiority adopted july 2000 concept paper on the development of a cpmp note for guidance on clinical investigation of medicinal products in the treatment of diabetes mellitus adopted july 2000 points to consider on clinical investigation of medicinal products for treatment of amyotrophic lateral sclerosis (als) adopted october 2000 concept paper on the evaluation of drugs for the treatment of the irritable bowel syndrome adopted november 2000 note for guidance on clinical investigation of medicinal products in the treatment of epileptic disorders adopted in november 2000 points to consider on clinical investigation of medicinal products for the management of crohn 's disease released for consultation july 2000